What is it about?
This study introduces a novel, minimally invasive approach to treating cancers located deep within the body. Researchers developed a tiny, flexible device that emits low-intensity red light and can be implanted directly into the body. When combined with a light-sensitive drug, this device activates a process called photodynamic therapy (PDT), which selectively kills cancer cells without harming surrounding healthy tissue. Traditional PDT methods are limited to surface or easily accessible tumors due to the challenges of delivering light deep into the body. However, this wireless, implantable device overcomes that limitation, offering a promising new treatment for hard-to-reach cancers. In animal studies, the therapy effectively reduced tumor size with minimal side effects, suggesting potential for future clinical applications.
Featured Image
Photo by Rosie Kerr on Unsplash
Why is it important?
This research marks the first successful demonstration of using a wireless, organic light-emitting diode (OLED) device for metronomic photodynamic therapy (mPDT) in deep-seated tumors. Unlike conventional PDT, which requires high-intensity light and is limited to surface tumors, this approach delivers continuous, low-intensity light directly to internal tumors, minimizing damage to healthy tissues. The device's wireless and flexible design allows for implantation in various body locations, expanding the potential reach of PDT. This innovation could revolutionize cancer treatment by providing a less invasive, targeted therapy option for patients with tumors previously considered inoperable or difficult to treat.
Perspectives
As one of the researchers involved in this study, I am thrilled by the potential impact of our work on cancer treatment. Developing a wireless, implantable device that can deliver targeted therapy to deep-seated tumors represents a significant advancement in the field. Our goal was to create a solution that not only effectively treats cancer but also reduces the burden on patients by minimizing side effects and avoiding invasive procedures. Seeing the promising results in our preclinical studies gives me hope that this technology will one day improve the lives of patients facing challenging cancer diagnoses.
YUJI MORIMOTO
National Defense Medical College, Japan
Read the Original
This page is a summary of: Metronomic photodynamic therapy for deep organ cancer by implantable wireless OLEDs, APL Bioengineering, April 2025, American Institute of Physics,
DOI: 10.1063/5.0256898.
You can read the full text:
Contributors
The following have contributed to this page
